Through
5/7
A round-up of Penn mentions in local, national, and international media.
Penn In the News
Kenneth Zaret of the Perelman School of Medicine says that the term “synthetic embryos” is misleading since they don’t have the potential to become human life.
Penn In the News
Neysun Mahboubi of the School of Arts & Sciences says that the resumption of people-to-people exchange is important in Sino-U.S. relations.
Penn In the News
Shelley Welton of Penn Carey Law looks at an airline’s claim that buying offsets compensates for the climate-change effects of air travel.
Penn In the News
Witold Henisz of the Wharton School says that there’s no logical tension between ESG investment and fiduciary duties.
Penn In the News
Jennifer Rothman of Penn Carey Law says that the Supreme Court will likely reverse the Federal Circuit trademark ban since it doesn’t invoke “viewpoint discrimination.”
Penn In the News
Susan Domchek of the Perelman School of Medicine is leading a trial for a preventive breast cancer vaccine.
Penn In the News
Barbara Hewitt of Career Services says that there are still opportunities for recent grads, though more students have to look beyond big-name companies.
Penn In the News
Michael Mann of the School of Arts & Sciences says that some climate change impacts are playing out faster and with a greater magnitude than predicted.
Penn In the News
PIK Professor Herbert Hovenkamp says that a dispute by a group of Puerto Rican jockeys was purely about compensation and labor issues, rather than separate economic activities that could raise antitrust issues.
Penn In the News
Atul Gupta of the Wharton School and the Leonard Davis Institute says that private equity may not be well-suited to the health care industry, which is riddled with imperfections.